Older patients with multiple comorbidities can be successfully treated with CAR T-cell therapy according to a real world audit of the first year of CAR T-cell therapy in the US. The study presented at ASH 2019 involved Medicare claims data from 207 patients, mostly with relapsed or refractory DLBCL, who received either axicabtagene ciloleucel or ...
CAR T-cell therapy real world outcomes: older patients treated successfully
By Mardi Chapman
10 Dec 2019